<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-03-28</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38539420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">Impact of Targeted Agents on Survival of Chronic Lymphocytic Leukemia Patients Fit for Fludarabine, Cyclophosphamide, and Rituximab (FCR) Relative to Age- and Sex-Matched Population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38539420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    To assess the impact of first-line treatment with targeted agents (TAs) or fludarabine, cyclophosphamide, and rituximab (FCR)-based chemo-immunotherapy (CIT) on overall survival (OS) compared to age- and sex-matched individuals in the general population, we conducted an aggregated analysis of phase 3 clinical trials, including the two FLAIR sub-studies, ECOG1912, and CLL13 trials. The restricted mean survival time (RMST), an alternative measure in outcome analyses capturing OS changes over &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38541169/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Sex Differences in Short- and Long-Term Survival after Acute Type A Aortic Dissection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38541169-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background and Objectives: Acute type A aortic dissection (AAD) is a life-threatening disease. No differences between men and women have been made in the treatment of AAD so far and knowledge about sex differences regarding long-term outcomes is limited. Materials and Methods: Between 01/2004 and 12/2021, 874 patients were operated on for AAD, including 313 (35.8%) women and 561 (64.2%) men. Clinical and surgical records, including long-term follow-up information, were obtained and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38541987/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Pleural Effusion and Chylothorax in Congenital Diaphragmatic Hernia-Risk Factors, Management and Outcome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38541987-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Pleural effusion and chylothorax are common complications in the treatment of congenital diaphragmatic hernia (CDH). We set out to identify risk factors for chylothorax development in patients with CDH and to investigate the association of pleural effusion and chylothorax with neonatal morbidity and mortality. Methods: In this retrospective cohort study, we included 396 neonates with CDH treated at our institution between January 2013 and June 2019. Preoperative and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542010/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Feasibility of Fluid Responsiveness Assessment in Patients at Risk for Increased Intracranial Pressure</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542010-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Effective fluid management is important for patients at risk of increased intracranial pressure (ICP). Maintaining constant cerebral perfusion represents a challenge, as both hypovolemia and fluid overload can severely impact patient outcomes. Fluid responsiveness tests, commonly used in critical care settings, are often deemed potentially hazardous for these patients due to the risk of disrupting cerebral perfusion. Methods: This single-center, prospective, clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542046/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Recalled Maternal Rearing Behaviour of Individuals Born Preterm and Their Mothers: The Impact of Intimate Mother-Child Contact</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542046-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Preterm birth is a risk factor for a variety of detrimental health outcomes. Previous studies have identified recalled (or remembered) parental rearing behaviour as a potential modifier of preterm individuals' mental health in adulthood. However, no investigations to date have contrasted the parents' and children&rsquo;s views, explored whether their congruence is associated with preterm individuals' mental health, or tested associations with maternal self-reported first &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542061/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Jozimine A&lt;sub&gt;2&lt;/sub&gt;, a Dimeric Naphthylisoquinoline (NIQ) Alkaloid, Shows In Vitro Cytotoxic Effects against Leukemia Cells through NF-κB Inhibition</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542061-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Naphthylisoquinoline (NIQ) alkaloids are rising as a promising class of secondary metabolites with pharmaceutical potential. NF-κB has already been recognized as a significant modulator of cancer proliferation and drug resistance. We have previously reported the mechanisms behind the cytotoxic effect of dioncophylline A, an NIQ monomer, in leukemia cells. In the current study, we have investigated the cytotoxic effect of jozimine A(2), an NIQ dimer, on leukemia cells in comparison to a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542193/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Peripheral Upregulation of Parkinson&#39;s Disease-Associated Genes Encoding α-Synuclein, β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542193-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Due to the high comorbidity of Parkinson&rsquo;s disease (PD) with major depressive disorder (MDD) and the involvement of sphingolipids in both conditions, we investigated the peripheral expression levels of three primarily PD-associated genes: α-synuclein (SNCA), lysosomal enzyme β-glucocerebrosidase (GBA1), and UDP-glucose ceramide glucosyltransferase (UGCG) in a sex-balanced MDD cohort. Normalized gene expression was determined by quantitative PCR in patients suffering from MDD (unmedicated n = &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542253/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Renin-Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived Colorectal Liver Metastasis Organoids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542253-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The recurrence of colorectal liver metastasis (CRLM) following liver resection is common; approximately 40% of patients will experience tumor recurrence post-surgery. Renin-angiotensin inhibitors (RASis) have been shown to attenuate the growth and progression of CRLM in pre-clinical models following liver resection. This study examined the efficacy of the RASi captopril on patient-derived colorectal liver metastasis organoids. Patient-derived organoids (PDOs) were established using fresh &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542263/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Beyond Quiescent and Active: Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542263-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Research on microglia in Down syndrome (DS) has shown that microglial activation, increased inflammatory gene expression, and oxidative stress occur at different ages in DS brains. However, most studies resulted in simplistic definitions of microglia as quiescent or active, ignoring potential intermediate states. Indeed, recent work on microglial cells in young DS brains indicated that those evolve through different intermediate activation phenotypes before reaching a fully activated state. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542409/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542409-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Elevated rates of human papillomavirus (HPV)-related anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer (AC) in populations like men who have sex with men (MSM) living with HIV underscore the need for effective screening. While high-resolution anoscopy-guided biopsy is the gold standard, limited provider availability poses a challenge. This has spurred interest in identifying biomarkers for improved AC prevention. Antibodies against HPV16 oncoprotein E6, known as markers &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542718/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Serum 25-Hydroxyvitamin D Status and Vitamin D Supplements Use Are Not Associated with Low Back Pain in the Large UK Biobank Cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542718-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Longitudinal studies assessing the association of vitamin D deficiency, defined by serum 25-hydroxyvitamin D levels &lt; 30 nmol/L, and vitamin D supplement (VDS) use with low back pain (LBP) are sparse. This investigation assessed the cross-sectional and longitudinal association of vitamin D status and VDS use with LBP among 135,934 participants from the UK Biobank cohort. Approximately 21.6% of the participants had vitamin D deficiency, while only 4% regularly took VDS. In the month before &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542750/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542750-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Circulating 25-hydroxyvitamin D (25(OH)D) is the generally accepted indicator of vitamin D status. Since hydroxylation of 25(OH)D to 24-25-dihydroxyvitamin D (24,25(OH)2D) is the first step of its catabolism, it has been suggested that a low 24,25(OH)D level and a low vitamin D metabolite ratio (VMR), i.e., 24,25(OH)2D divided by 25(OH)D, may indicate high vitamin D requirements and provide additional diagnostic information beyond serum 25(OH)D. We, therefore, evaluated whether &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38543840/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">A New Inovirus from the Human Blood Encodes Proteins with Nuclear Subcellular Localization</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38543840-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Viruses infecting bacteria (bacteriophages) represent the most abundant viral particles in the human body. They participate in the control of the human-associated bacterial communities and play an important role in the dissemination of virulence genes. Here, we present the identification of a new filamentous single-stranded DNA phage of the family Inoviridae, named Ralstonia Inoviridae Phage 1 (RIP1), in the human blood. Metagenomics and PCR analyses detected the RIP1 genome in blood serum, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38544797/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38544797-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Assessment of cardiovascular risk is critical for patients with cancer. Previous retrospective studies suggest potential cardiotoxicity of CAR T cell therapies. We aimed to prospectively assess cardiotoxicity and the predictive value of cardiac biomarkers and classical risk factors (age, cardiac function, diabetes, arterial hypertension, smoking) for cardiac events and all-cause mortality &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545806/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Parents&#39; Views on Prolonged Maternal Hospital Stay With Sick Newborn Infants in a Tertiary Neonatal Unit in Sri Lanka</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545806-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Mothers of infants in most Sri Lankan neonatal units are required to be &ldquo;inpatients&rdquo; during the entirety of their infant&rsquo;s stay. This traditional practice is closely aligned to the relatively newer model of family-integrated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545827/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545827-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Salivary duct carcinomas (SDC) of the parotid gland are rarely occurring highly malignant tumors. A 65-year-old man presented with a preauricular mass. After surgical treatment and histologic examination, the findings were interpreted as a squamous cell carcinoma (SCC) metastasis of the parotid gland deriving from a cancer of unknown primary DD primary SCC of the parotid gland. Adjuvant platinum-based radiochemotherapy was administered in domo. However, re-staging revealed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545829/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545829-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The data indicate that M1 metastases kill more patients in the first 2.5 years than between years 2.5 and 5 after diagnosis; T4 deaths are equal in the two periods, and in T3 mortality in the first 2.5-year period is lower than between years 2.5 and 5 after diagnosis. Conditional survival could be applied to explore critical survival periods even past 5 years after diagnoses and to monitor success in novel diagnostic and treatment practices. Improvement of survival in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545840/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545840-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings demonstrate the potential value of MerTK as a prognostic biomarker for gastric adenocarcinoma. Targeting MerTK may become a new treatment option, especially for patients with advanced tumors, and may overcome resistance to established &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545850/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545850-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546297/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Co-prevalence of arterial aneurysm location - a correlation analysis based on a retrospective cross-sectional observational study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546297-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The aim of this retrospective single-centre cross-sectional observational study was to investigate co-prevalence of arterial aneurysm location systematically. Patients and methods: Patients with the diagnosis of any arterial aneurysm from January 2006 to January 2016 were investigated in a single centre. Patients with hereditary disorders of connective tissue, systemic inflammatory disease, or arterial pathologies other than true aneurysms were excluded. Aneurysm locations &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546633/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">Zinzani PL, Thieblemont C, Melnichenko V, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. Blood. 2023;142(2):141-145</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546633-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546634/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">An unusual presentation of lymphoplasmacytic lymphoma with isolated brachial plexus infiltration and amyloidosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546634-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546635/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">AL amyloidosis response: a move in the &#34;light&#34; direction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546635-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546636/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">T-cell lymphoma: the CAR-T revolution is coming</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546636-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546637/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">GPR56 in GVL: marker or mechanism?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546637-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">TP53 function over forms in multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546638-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546639/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">Ironing erythroid cells takes FLG1 and ERFE to tango</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546639-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546640/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">Sickle cell anemia: hepatic macrophages to the rescue</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546640-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546696/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is little long-term outcome data on the efficacy of autologous hematopoietic stem cell transplantation (ASCT) in light chain deposition disease (LCDD). We identified 51 LCDD patients in the EBMT registry who had undergone upfront ASCT between 1995 and 2021. The median serum creatinine was 280 μmol/L and 45% required renal replacement therapy (RRT) at time of transplant. The melphalan dose was 100mg/m2 in 23%, 140mg/m2 in 55% and 200 mg/m2 in 21%. The rate of very good partial response &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O73m8zH8R">HIV治愈研究最新进展。今天Science上线了一篇重要HIV治愈文章，这实际上是2020年11月NIH Strategies for HIV Cure会议已经报道的数据（网页链接），即N-803 &#43; 3B...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o73m8zh8r/">
    
    
    
    
    
      
    
    HIV治愈研究最新进展。今天Science上线了一篇重要HIV治愈文章，这实际上是2020年11月NIH Strategies for HIV Cure会议已经报道的数据（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->），即N-803 + 3BNC117 + 10-1074可以使停止抗病毒药后的恒河猴病毒载量反弹逐渐消失。<!-- raw HTML omitted --><!-- raw HTML omitted -->N-803由Patrick Soon-Shiong（陈颂雄）的ImmunityBio公 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O74cyDmly">一些朋友问美国生物医学工业界最近的就业情况。我在置顶微博讲了生物医学PhD找工业界工作的一些方法（网页链接）；但最近我收到一些反馈，认为最近一年左右，在...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o74cydmly/">
    
    
    
    
    
      
    
    一些朋友问美国生物医学工业界最近的就业情况。我在置顶微博讲了生物医学PhD找工业界工作的一些方法（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）；但最近我收到一些反馈，认为最近一年左右，在美国找health industry包括biotech和药厂的工作异常艰难，尤其是没有绿卡的同学找这些工 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O75DJAvnI">特别推荐上周四NPR历史Podcast - Throughline节目关于美国禁书的一期节目，十分精彩。这期节目解读了美国意识形态教育的历史。最近我看了一个对某个国内第六代导...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o75djavni/">
    
    
    
    
    
      
    
    特别推荐上周四NPR历史Podcast - Throughline节目关于美国禁书的一期节目，十分精彩。这期节目解读了美国意识形态教育的历史。最近我看了一个对某个国内第六代导演的采访，他大意说，每个国家都会陷入自身的历史循环，这源于一代一代传承的教育和由此形成的民族性格。美国有典型的历史循环，而现在许多荒诞不经的现实都可以在历史上找到类似的经历。<!-- raw HTML omitted --><!-- raw HTML omitted -->比如禁书。过去三年，佛罗里达州长Ron DeSantis为了迎合美国极右翼势力以竞选总统，在该州开展了大量禁书活动（<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O75rY5RzY">给点提示，主角很胖 - 转发 @博集天卷:&amp;ensp;[抱一抱]噔噔噔，前方编辑传来印厂视频！全网催更的@马伯庸 老师新书已经开始印刷了，大家一起瞧瞧是哪本书（答案藏...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o75ry5rzy/">
    
    
    
    
    
      
    
    给点提示，主角很胖<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@博集天卷<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->噔噔噔，前方编辑传来印厂视频！<!-- raw HTML omitted --><!-- raw HTML omitted -->全网催更的<!-- raw HTML omitted -->@马伯庸<!-- raw HTML omitted --> 老师新书已经开始印刷了，大家一起瞧瞧是哪本书（答案藏在视频里）~<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[举手]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/fd/2022_raisehand_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/fd/2022_raisehand_org.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O76DybUWe">马小烦昨天经历了人生第一次突然的诀别。还好，不是和人，也不是和小动物，而是一家日式拉面小店。但对他来说，伤心程度并无不同。马小烦上小学之后，我们搬到了...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o76dybuwe/">
    
    
    
    
    
      
    
    马小烦昨天经历了人生第一次突然的诀别。<!-- raw HTML omitted --><!-- raw HTML omitted -->还好，不是和人，也不是和小动物，而是一家日式拉面小店。但对他来说，伤心程度并无不同。<!-- raw HTML omitted --><!-- raw HTML omitted -->马小烦上小学之后，我们搬到了现在住的小区。这个小区对面有一个商场，那家拉面店就在一层临街的位置，出了小区过马路就到。<!-- raw HTML omitted --><!-- raw HTML omitted -->我们第一次来吃，是因为马小烦报名了一家足球俱乐部，第一次训练就累得臭死，饥肠辘辘，他回家一路上不停地嗷嗷待哺。出租车停下的位置，恰好就在这家店门口，小东西累得一步都不肯多走，我们就直接推门进去。<!-- raw HTML omitted --><!-- raw HTML omitted -->小店的装潢没什么特色，屋子也不宽敞。店里除了寻常的豚骨或味噌拉面之外，菜单上还有一款鸡汤盐味拉面。恰好我刚读到贾平凹写耀县盐汤面的 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79IeCQMS">🔻一个试图在科罗拉多州众议院推动通过“蒂亚拉法”的组织。该法律将使变性罪犯更容易改名、逃避身份识别和隐藏犯罪记录。它以变装皇后、重罪犯和性工作者蒂亚...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79iecqms/">
    
    
    
    
    
      
    
    🔻一个试图在科罗拉多州众议院推动通过“蒂亚拉法”的组织。该法律将使变性罪犯更容易改名、逃避身份识别和隐藏犯罪记录。它以变装皇后、重罪犯和性工作者蒂亚拉的名字命名。<!-- raw HTML omitted -->🔻“美国新质生产力”<!-- raw HTML omitted -->🔻源：libsoftiktok <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79LPh69g">🔻法国发言人称联合国停火决议具有约束力：“根据国际法，联合国安全理事会的决议具有约束力。所有有关各方都必须执行该决议，特别是以色列，它有义务执行该决...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79lph69g/">
    
    
    
    
    
      
    
    🔻法国发言人称联合国停火决议具有约束力：“根据国际法，联合国安全理事会的决议具有约束力。所有有关各方都必须执行该决议，特别是以色列，它有义务执行该决议。”<!-- raw HTML omitted -->🔻源：Arnaud Bertrand<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#安理会首次通过明确要求 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79O1wvq7">[思考]七天之后再来看订单数据，可能比较准//@小的32636:真有人信啊，强如特斯拉今年一月model y 也才五万辆，小米半个小时就五万了?小米的营销策略还有人看不明...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79o1wvq7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->七天之后再来看订单数据，可能比较准//<!-- raw HTML omitted -->@小的32636<!-- raw HTML omitted -->:真有人信啊，强如特斯拉今年一月model y 也才五万辆，小米半个小时就五万了?小米的营销策略还有人看不明白啊，从手机开始一直都这样<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79SE5UIB">🔻俄军 坠 机 新视频，看着像 Su-27🔻塞瓦斯托波尔本地频道说优先考虑机械故障，因为没有看到防空运行的迹象。🔻源：Чп / Севастополь</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79se5uib/">
    
    
    
    
    
      
    
    🔻俄军 坠 机 新视频，看着像 Su-27<!-- raw HTML omitted -->🔻塞瓦斯托波尔本地频道说优先考虑机械故障，因为没有看到防空运行的迹象。<!-- raw HTML omitted -->🔻源：Чп / Севастополь <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/sG4hoVMOlx08dEgQthtC010412004kTd0E0">https://f.video.weibocdn.com/o0/sG4hoVMOlx08dEgQthtC010412004kTd0E0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79W1DdYS">🔻我要向你们介绍土侄们的“自由主义救世主”：阿根廷总统米莱说，“以色列没有任何过激行为。”🔻源：CNN 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79w1ddys/">
    
    
    
    
    
      
    
    🔻我要向你们介绍土侄们的“自由主义救世主”：阿根廷总统米莱说，“以色列没有任何过激行为。”<!-- raw HTML omitted -->🔻源：CNN <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.we">https://f.video.we</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79XjxZll">🔻[哆啦A梦吃惊]#小米SU7价格# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79xjxzll/">
    
    
    
    
    
      
    
    🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#小米SU7价格#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7a9Mnq20">🔻刷了一圈主页，我发现说“今年不买车”的我跟首页显得有点格格不入……#小米SU7价格#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7a9mnq20/">
    
    
    
    
    
      
    
    🔻刷了一圈主页，我发现说“今年不买车”的我跟首页显得有点格格不入……<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#小米SU7价格#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7adfhfTP">🔻首页都在上顶配，然后这条也夹在热搜里。🔻上网基数还是太大了。#存款到10万是什么感觉# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7adfhftp/">
    
    
    
    
    
      
    
    🔻首页都在上顶配，然后这条也夹在热搜里。<!-- raw HTML omitted -->🔻上网基数还是太大了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#存款到10万是什么感觉#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7aEq9WnX">🔻睡前看了下陈志新老师的社会科学概论，点开第一讲，凌晨2点半还有1000多人在线看，第二讲有741个人正在看。🔻陈老师现在有71万粉丝，第一讲的序言是全站热...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7aeq9wnx/">
    
    
    
    
    
      
    
    🔻睡前看了下陈志新老师的社会科学概论，点开第一讲，凌晨2点半还有1000多人在线看，第二讲有741个人正在看。<!-- raw HTML omitted -->🔻陈老师现在有71万粉丝，第一讲的序言是全站热度第一。<!-- raw HTML omitted -->🔻随便平时怎么调侃甜站，有这么多人愿意认认真真看老师认认真真讲的课，真的很高兴。<!-- raw HTML omitted -->🔻晚安。<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%AF%BE%23&amp;amp;extparam=%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%25A">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%AF%BE%23&amp;amp;extparam=%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7aiqt9YK">🔻与此同时，看看 tiktok 上的美国小视频：“我公司同事买车的情况，以及每个月的车贷。”🔻考虑到他们都是为道奇经销商工作，作为员工可以享受折扣以及比较...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7aiqt9yk/">
    
    
    
    
    
      
    
    🔻与此同时，看看 tiktok 上的美国小视频：“我公司同事买车的情况，以及每个月的车贷。”<!-- raw HTML omitted -->🔻考虑到他们都是为道奇经销商工作，作为员工可以享受折扣以及比较好的车贷计划，但普通市民很难负担更高的车款。<!-- raw HTML omitted -->🔻感觉和中国的购车现状已经是两个世界间的比较了。<!-- raw HTML omitted -->🔻月供 1298 美元购买一辆 Jeep……<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#小米SU7价格#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/O76ngrNhg">接完电话愤怒的把前前老板的备注改成了老登[怒]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-o76ngrnhg/">
    
    
    
    
    
      
    
    接完电话愤怒的把前前老板的备注改成了老登<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O757OoetW">重温老孵蛋生活 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o757ooetw/">
    
    
    
    
    
      
    
    重温老孵蛋生活 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O76MBkdcZ">//@顶筆TEN使:久保史绪里 - 转发 @乃木坂46:&amp;ensp;📸#乃木坂46GALLERY#📸[抱一抱]#3期生# Works[抱一抱]乃木坂46 #梅泽美波# #久保史绪里# #佐藤枫# #向井叶...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o76mbkdcz/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@乃木坂46<!-- raw HTML omitted -->: 📸&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?contai">https://m.weibo.cn/search?contai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O76MwhIAW">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.mdrp part.1 [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o76mwhiaw/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.1 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t1dfcjcj318g0tl47w.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t1dfcjcj318g0tl47w.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O76MxAgYV">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.mdrp part.2 [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o76mxagyv/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.2 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3msxkvj318g0tl157.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3msxkvj318g0tl157.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O77Sbjk5Y">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.BUBKA_henshuubu 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o77sbjk5y/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O77SMl2WT">困得很蹊跷</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o77sml2wt/">
    
    
    
    
    
      
    
    困得很蹊跷  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O7800eCFM">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.BUBKA_henshuubu [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o7800ecfm/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6ydi5rakj323v35s4qp.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6ydi5rakj323v35s4qp.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79YkFoHp">转发微博 - 转发 @山下美月教会:&amp;ensp;山下美月#山下美月手机博# 240328.1「迟了山」迟了山困得有点厉害一个不注意刚才手机砸脸上了很疼的那种呢想着山下的困倦...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79ykfohp/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->山下美月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79Zbgl0V">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.seventeen 官网 [图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79zbgl0v/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen 官网 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho73apm0brj30ku0rsdjg.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho73apm0brj30ku0rsdjg.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79ZemrCX">升天 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里BUBKA 5月号 part.1※组内自购 请勿外传※※無断転載お断り※ [图片][图片][图片][图片][图片][图片][图片][图片][图片...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79zemrcx/">
    
    
    
    
    
      
    
    升天<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5月号 part.1<!-- raw HTML omitted -->※组内自购 请勿外传※<!-- raw HTML omitted -->※無断転載お断り※ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho74d">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho74d</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79ZqC79h">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里BUBKA 5月号 part.2※组内自购 请勿外传※※無断転載お断り※ [图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79zqc79h/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5月号 part.2<!-- raw HTML omitted -->※组内自购 请勿外传※<!-- raw HTML omitted -->※無断転載お断り※ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1h">https://tvax1.sinaimg.cn/large/006z6nxLgy1h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O74kIoFuj">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.乃木恋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o74kiofuj/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木恋 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6cyyl99zj30xc18g4d6.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6cyyl99zj30xc18g4d6.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O76y9dhpr">期待久保的鹽麵包食譜[哈哈][二哈] [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o76y9dhpr/">
    
    
    
    
    
      
    
    期待久保的鹽麵包食譜<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/005TCz76gy1ho6s2ic8nej31gc0u0wjl.jpg%22">https://tvax4.sinaimg.cn/large/005TCz76gy1ho6s2ic8nej31gc0u0wjl.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O77jtBefN">偶像手作麵包 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o77jtbefn/">
    
    
    
    
    
      
    
    偶像手作麵包 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O77TLAtCm">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.BUBKA_henshuubu 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o77tlatcm/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O77TW664R">分享图片 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o77tw664r/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O78E54sIM">小虎牙[哈哈] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o78e54sim/">
    
    
    
    
    
      
    
    小虎牙<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O78MfEmh4">總覺得久保在拍17照片時很累 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o78mfemh4/">
    
    
    
    
    
      
    
    總覺得久保在拍17照片時很累 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O79n8nIWH">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里BUBKA 5月号 part.1※组内自购 请勿外传※※無断転載お断り※ [图片][图片][图片][图片][图片][图片][图片][图片][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o79n8niwh/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5月号 part.1<!-- raw HTML omitted -->※组内自购 请勿外传※<!-- raw HTML omitted -->※無断転載お断り※ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho7">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho7</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O79norKbb">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里BUBKA 5月号 part.2※组内自购 请勿外传※※無断転載お断り※ [图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o79norkbb/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5月号 part.2<!-- raw HTML omitted -->※组内自购 请勿外传※<!-- raw HTML omitted -->※無断転載お断り※ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1h">https://tvax1.sinaimg.cn/large/006z6nxLgy1h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O73xod3RN">棋手战鹰说实话我还真想看看鹰子怎么cos俞妹妹 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o73xod3rn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->说实话我还真想看看鹰子怎么cos俞妹妹 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O74lxn1jT">日本棋院在今年7月17日迎来创立100周年，我打算从4月1日开始逐步更新一下日本棋院的100周年纪念连载有这两个连载· 100名棋手的“令我印象深刻的一手棋”· 日本...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o74lxn1jt/">
    
    
    
    
    
      
    
    日本棋院在今年7月17日迎来创立100周年，我打算从4月1日开始逐步更新一下日本棋院的100周年纪念连载<!-- raw HTML omitted --><!-- raw HTML omitted -->有这两个连载<!-- raw HTML omitted -->· 100名棋手的“令我印象深刻的一手棋”<!-- raw HTML omitted -->· 日本围棋百大奠基人<!-- raw HTML omitted -->嗯，多写200篇东西，还好也不算太长<!-- raw HTML omitted --><!-- raw HTML omitted -->不难否认我心中的某个角落会说：“你特么又给自己添麻烦”，不过考虑到日本棋院110周年的时候，或许不会有这么大的连载。与其不写让我留下遗憾，不如先翻了再说。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%9B%B4%E6%A3%8B&amp;amp;containerid=10080864408f17859127e">https://m.weibo.cn/p/index?extparam=%E5%9B%B4%E6%A3%8B&amp;amp;containerid=10080864408f17859127e</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O77Tit3Kh">棋手战鹰 这脸怎么，大了一圈？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o77tit3kh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->这脸怎么，大了一圈？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O79m5sIBA">发布了头条文章：《从AlphaGo的“1败”捕捉人类生存策略》 #围棋# 围棋 从AlphaGo的“1败”捕捉人类生存策略 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o79m5siba/">
    
    
    
    
    
      
    
    发布了头条文章：《从AlphaGo的“1败”捕捉人类生存策略》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O75Jmfh6p">久保史绪里 via.kaiki_rupo4月4日（周四）开始每周25点（JST），全六回初回MC：佐久間宣行嘉宾：呂布カルマ/蓮見翔（ダウ90000）/久保史绪里（乃木坂46） [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o75jmfh6p/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.kaiki_rupo<!-- raw HTML omitted -->4月4日（周四）开始每周25点（JST），全六回<!-- raw HTML omitted -->初回<!-- raw HTML omitted -->MC：佐久間宣行<!-- raw HTML omitted -->嘉宾：呂布カルマ/蓮見翔（ダウ90000）/<!-- raw HTML omitted -->久保史绪里（乃木坂46） &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy">https://tvax2.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O76LwbfhG">久保史绪里via.mdrp part.1 [图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o76lwbfhg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.1 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6t1e1901">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6t1e1901</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O76M54uaY">久保史绪里via.mdrp part.2 [图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o76m54uay/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.2 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3n8sc4">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3n8sc4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O76M9lrhc">久保史绪里 - 转发 @乃木坂46:&amp;ensp;📸#乃木坂46GALLERY#📸[抱一抱]#3期生# Works[抱一抱]乃木坂46 #梅泽美波# #久保史绪里# #佐藤枫# #向井叶月# [图片][图...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o76m9lrhc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@乃木坂46<!-- raw HTML omitted -->: 📸&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O77O0xHA8">久保史绪里via.BUBKA_henshuubu 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o77o0xha8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25">https://h5.sinaimg.cn/upload/2015/09/25</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O77Y7nCN3">久保史绪里via.BUBKA_henshuubu [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o77y7ncn3/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6y">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6y</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O795fmBpi">久保史绪里via.seventeen 官网 [图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o795fmbpi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen 官网 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1ho73ap">https://tvax1.sinaimg.cn/large/006z6nxLgy1ho73ap</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O79kCjf2I">久保史绪里BUBKA 5月号 part.2※组内自购 请勿外传※※無断転載お断り※ [图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o79kcjf2i/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5月号 part.2<!-- raw HTML omitted -->※组内自购 请勿外传※<!-- raw HTML omitted -->※無断転載お断り※ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O79kjnqi4">久保史绪里BUBKA 5月号 part.1※组内自购 请勿外传※※無断転載お断り※ [图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o79kjnqi4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5月号 part.1<!-- raw HTML omitted -->※组内自购 请勿外传※<!-- raw HTML omitted -->※無断転載お断り※ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sin">https://tvax2.sin</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O7aDJ9c1U">久保史绪里bubka拼页 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o7adj9c1u/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->bubka拼页 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O78H5shUv">柯洁#雅居乐清水湾杯中国围棋甲级联赛##赛事报道#3月26日，深圳市文化广电旅游体育局向深圳龙华围棋队发去贺信，祝贺其在2023“雅居乐清水湾杯”中国围棋甲级联...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o78h5shuv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/03/28/1198908668/a-history-of-hezbollah">A History of Hezbollah</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-03-28-1198908668-a-history-of-hezbollah/">
    
    
    
    
    
      
    
    Hezbollah is a Lebanese paramilitary organization and political party that&rsquo;s directly supported by the Islamic Republic of Iran. In the wake of the October 7, 2023 Hamas-led attack on Israel, and Israel&rsquo;s invasion of Gaza, Hezbollah and Israel have been exchanging missile fire across the border they share, causing growing fears of a regional conflict with the U.S. and Israel on one side and Iran along with its allies in Hezbollah, Hamas, and the Houthi rebels of Yemen on the other.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38531863/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">How comparable are patient outcomes in the &#34;real-world&#34; with populations studied in pivotal AML trials?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38531863-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite an increasing desire to use historical cohorts as &ldquo;synthetic&rdquo; controls for new drug evaluation, limited data exist regarding the comparability of real-world outcomes to those in clinical trials. Governmental cancer data often lacks details on treatment, response, and molecular characterization of disease sub-groups. The Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry (ALLG NBCR) includes source information on morphology, cytogenetics, flow cytometry, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38531926/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38531926-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cardiac Troponin I (cTnI) could be used to identify individuals at elevated risk of cardiac death in lung cancer (LC) screening settings. In a population-based, randomized LC screening trial in Germany (&ldquo;LUSI&rdquo; study) serum cTnI was measured by high-sensitivity assay in blood samples collected at baseline, and categorized into unquantifiable/low (&lt; 6 ng/L), intermediate (≥ 6-15 ng/L), and elevated (≥ 16 ng/L). Cox proportional-hazard models were used to estimate risk of all-cause and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532040/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Light Cannabis Use and the Adolescent Brain: An 8-years Longitudinal Assessment of Mental Health, Cognition, and Reward Processing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532040-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Impairments in reward-related brain activity and cognitive functioning do not appear to precede or succeed cannabis use (i.e., weekly, or monthly use). Cannabis-naïve adolescents with conduct problems and more socially engaged with their peers may be at a greater risk for lighter yet persistent cannabis use in the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532323/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240327180710&amp;v=2.18.0.post9&#43;e462414">Neuro-protective Effect of Acetyl-11-keto-β-boswellic Acid in a Rat Model of Scopolamine-induced Cholinergic Dysfunction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532323-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240327180710-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The results suggested the effectiveness of AKBA in preventing learning and memory dysfunction induced by scopolamine. Accordingly, these protective effects might be produced by modulating BDNF, cholinergic system function, oxidative stress, and apoptotic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532323/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240328180649&amp;v=2.18.0.post9&#43;e462414">Neuro-protective Effect of Acetyl-11-keto-β-boswellic Acid in a Rat Model of Scopolamine-induced Cholinergic Dysfunction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532323-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240328180649-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The results suggested the effectiveness of AKBA in preventing learning and memory dysfunction induced by scopolamine. Accordingly, these protective effects might be produced by modulating BDNF, cholinergic system function, oxidative stress, and apoptotic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532336/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532336-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The PATHFINDER-CHD Registry is poised to offer valuable insights into HF management in ACHD, bridging current knowledge gaps, enhancing patient care, and shaping future research endeavors in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532495/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532495-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We performed the first double-stratified GWAS of PCSK9 levels and identified multiple biologically plausible loci with genetic interaction effects. Our results indicate that the observed sexual dimorphism of PCSK9 and its statin-related interactions have a genetic basis. Significant differences in the causal relationship between PCSK9 and LDL-C suggest sex-specific dosages of PCSK9 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532575/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240327180717&amp;v=2.18.0.post9&#43;e462414">Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532575-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240327180717-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of haematological cancers with generally poor clinical outcomes. However, a subset of patients experience durable disease control, and little is known regarding long-term outcomes. The International T-cell Lymphoma Project (ITCLP) is the largest prospectively collected cohort of patients with PTCLs, providing insight into clinical outcomes at academic medical centres globally. We performed a long-term outcome analysis on patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532575/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532575-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of haematological cancers with generally poor clinical outcomes. However, a subset of patients experience durable disease control, and little is known regarding long-term outcomes. The International T-cell Lymphoma Project (ITCLP) is the largest prospectively collected cohort of patients with PTCLs, providing insight into clinical outcomes at academic medical centres globally. We performed a long-term outcome analysis on patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532741/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Post-COVID syndrome and work ability 9-12 months after a SARS-CoV-2 infection among over 9000 employees from the general population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532741-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings revealed risk factors of mWAI &lt;P15 and associations of post-COVID symptom clusters with WAI &lt;P15, which could be potentially prioritized for targeting rehabilitation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532825/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532825-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The morphological patterns leading to the diagnosis of glioblastoma may also commonly be observed in several other distinct tumor entities, which can result in a mixed bag of tumors subsumed under this diagnosis. The 2021 WHO Classification of CNS Tumors has separated several of these entities from the diagnosis of glioblastoma, IDH-wildtype. This study determines the DNA methylation classes most likely receiving the diagnosis glioblastoma, IDH wildtype according to the definition by the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533237/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Hot avulsion &lt;em&gt;versus&lt;/em&gt; argon plasma coagulation for the management of the non-ensnarable polyp: A multicenter, randomized controlled trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533237-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Both hot avulsion and argon plasma coagulation are effective and safe modalities to complete resection of non-ensnarable colonic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533342/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Co-occurrence of and factors associated with health risk behaviors among adolescents: a multi-center study in sub-Saharan Africa, China, and India</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533342-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Despite lifelong and detrimental effects, the co-occurrence of health risk behaviors (HRBs) during adolescence remains understudied in low- and middle-income countries. This study examines the co-occurrence of HRBs and its correlates among adolescents in sub-Saharan Africa, China, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533391/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Personality and the use of cancer screenings - Results of the German National Cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533391-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Particularly higher levels of extraversion, neuroticism and conscientiousness are associated with the use of different cancer screenings. Such knowledge may help to better understand non-participation in cancer screening examinations from a psychological &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533580/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533580-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The methyl-lysine reader protein SPIN1 plays important roles in various human diseases. However, targeting methyl-lysine reader proteins has been challenging. Very few cellularly active SPIN1 inhibitors have been developed. We previously reported that our G9a/GLP inhibitor UNC0638 weakly inhibited SPIN1. Here, we present our comprehensive structure-activity relationship study that led to the discovery of compound 11, a dual SPIN1 and G9a/GLP inhibitor, and compound 18 (MS8535), a SPIN1 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534054/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240327180717&amp;v=2.18.0.post9&#43;e462414">Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534054-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240327180717-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Orbital plasmacytoma is a rare plasma cell tumor that may arise as an aggressive form of extramedullary multiple myeloma. Treatment modalities include surgical excision, radiation, and chemotherapy. Chimeric antigen receptor T cell therapy is currently reserved for refractory disease. The authors present a case of a 69-year-old woman with an extensive orbital plasmacytoma refractory to multimodal therapy who was treated with idecabtagene vicleucel chimeric antigen receptor T cell therapy. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534054/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534054-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Orbital plasmacytoma is a rare plasma cell tumor that may arise as an aggressive form of extramedullary multiple myeloma. Treatment modalities include surgical excision, radiation, and chemotherapy. Chimeric antigen receptor T cell therapy is currently reserved for refractory disease. The authors present a case of a 69-year-old woman with an extensive orbital plasmacytoma refractory to multimodal therapy who was treated with idecabtagene vicleucel chimeric antigen receptor T cell therapy. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240327180714&amp;v=2.18.0.post9&#43;e462414">Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240327180714-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cancer is a complex and evolutionary disease mainly driven by the accumulation of genetic variations in genes. Identifying cancer driver genes is important. However, most related studies have focused on the population level. Cancer is a disease with high heterogeneity. Thus, the discovery of driver genes at the individual level is becoming more valuable but is a great challenge. Although there have been some computational methods proposed to tackle this challenge, few can cover all &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240328180651&amp;v=2.18.0.post9&#43;e462414">Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240328180651-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cancer is a complex and evolutionary disease mainly driven by the accumulation of genetic variations in genes. Identifying cancer driver genes is important. However, most related studies have focused on the population level. Cancer is a disease with high heterogeneity. Thus, the discovery of driver genes at the individual level is becoming more valuable but is a great challenge. Although there have been some computational methods proposed to tackle this challenge, few can cover all &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535045/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Photon-Counting Detector CT Virtual Monoenergetic Images in Cervical Trauma Imaging-Optimization of Dental Metal Artifacts and Image Quality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535045-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our research suggests 70 keV might be the best compromise for reducing metal artifacts affecting vascular structures and preventing vascular contrast if solely using VME reconstructions. VME imaging shows only significant effects on the general artifact burden. Vascular structures generally experience fewer metal artifacts than soft tissue due to their greater distance from the teeth, which are a common source of such &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535047/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Optimizing Arterial Vessel Contrast in Portal Venous Phase with Virtual Monoenergetic Images from Photon-Counting Detector CT Scans of the Abdomen-First Clinical Experiences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535047-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our research suggests that virtual monoenergetic images at 40 keV in Mono+ mode derived from a PCD-CT can be a feasible alternative to a true arterial phase for assessment of vessels with worse CNR and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535070/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Comparison between Ultrasound-Guided and Palpatory Localization of the Dorsal Joint Space of the Shoulder Joint</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535070-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Based on the results, the authors recommend ultrasound imaging of the shoulder joint as well as ultrasound-assisted punctures, especially for inexperienced users. Furthermore, training in ultrasound-assisted interventions should be implemented in future training &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535121/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">New Cases of Maleylacetoacetate Isomerase Deficiency with Detection by Newborn Screening and Natural History over 32 Years: Experience from a German Newborn Screening Center</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535121-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Newborn screening (NBS) for hepatorenal tyrosinemia type I (HT1) based on a determination of succinylacetone is performed in countries worldwide. Recently, biallelic pathogenic variants in GSTZ1 underlying maleylacetoacetate isomerase (MAAI) deficiency have been described as a differential diagnosis in individuals with slightly elevated succinylacetone detected by NBS. We report the experience with NBS for HT1 over 53 months in a large German NBS center and the identification &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535528/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535528-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cutaneous T-cell lymphoma (CTCL) is a devastating, potentially fatal T-lymphocyte malignancy affecting the skin. Despite all efforts, the etiology of this disease remains unknown. Infectious agents have long been suspected as factors or co-factors in CTCL pathogenesis. This review deals with the panel of bacterial and viral pathogens that have been investigated so far in an attempt to establish a potential link between infection/carriage and CTCL development. A special focus is given to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535773/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Photon Counting Computed Tomography for Accurate Cribriform Plate (Lamina Cribrosa) Imaging in Adult Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535773-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Detailed visualization of the cribriform plate is challenging due to its intricate structure. This study investigates how computed tomography (CT) with a novel photon counting (PC) detector enhance cribriform plate visualization compared to traditionally used energy-integrated detectors in patients. A total of 40 patients were included in a retrospective analysis, with half of them undergoing PC CT (Naeotom Alpha Siemens Healthineers, Forchheim, Germany) and the other half undergoing CT &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38536110/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38536110-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Rationale: Cough is a key symptom in patients with fibrotic interstitial lung disease (ILD). Objective: This study evaluated the prevalence, longitudinal change, associations, and prognostic significance of cough severity in patients with fibrotic ILD. Methods: We included consecutive patients with idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic ILD who completed the 100mm-Cough Severity Visual Analog Scale (VAS) from the prospective multi-center Canadian Registry for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38537633/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38537633-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hispanic/Latino children have the highest risk of acute lymphoblastic leukemia (ALL) in the US compared to other racial/ethnic groups, yet the basis of this remains incompletely understood. Through genetic fine-mapping analyses, we identified a new independent childhood ALL risk signal near IKZF1 in self-reported Hispanic/Latino individuals, but not in non-Hispanic White individuals, with an effect size of ∼1.44 (95% confidence interval = 1.33-1.55) and a risk allele frequency of ∼18% &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O6UegaOOl">新型冠状病毒SARS-CoV-2等跨种传播传染病（Zoonotic）是怎么从自然界传播到人类的？为什么会传播到人类？两年前Peter Daszak和Shi Zheng-Li等合作的文章就探讨了...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o6uegaool/">
    
    
    
    
    
      
    
    新型冠状病毒SARS-CoV-2等跨种传播传染病（Zoonotic）是怎么从自然界传播到人类的？为什么会传播到人类？两年前Peter Daszak和Shi Zheng-Li等合作的文章就探讨了原因（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->），主要原因是携带人畜共患病毒动物 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O6VVplGYZ">NIH 2024年预算不会减少。美国生物医学领域有大量中国学生学者依赖NIH经费，所以对他们而言这无疑是个喜讯。上周六凌晨，Biden签署了最终的2024年预算法案，这场...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o6vvplgyz/">
    
    
    
    
    
      
    
    NIH 2024年预算不会减少。美国生物医学领域有大量中国学生学者依赖NIH经费，所以对他们而言这无疑是个喜讯。<!-- raw HTML omitted --><!-- raw HTML omitted -->上周六凌晨，Biden签署了最终的2024年预算法案，这场长达6个月旷日持久的预算斗争终于宣告结束，以两党妥协告终。每年10月1日是美国联邦政府财政年开始，9月30日前国会必须通过下一年财政预算以避免联邦政府shutdown。因为国会参议院、众议院分属不同党派，本应该2023年10月1日前通过的2024年预算法案一直没有通过，而只是以stopgap（临时预算）的形式维持到了现在。2023年GOP控制的众议院扬言要削减NIH 5.8%预算，这将近28亿美元（<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70IF2dq1">🔻艾布拉姆斯。🔻源：Кирилл Фёдоров [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70if2dq1/">
    
    
    
    
    
      
    
    🔻艾布拉姆斯。<!-- raw HTML omitted -->🔻源：Кирилл Фёдоров <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70QltLgv">🔻注册号为 A6-EDM 的阿联酋航空公司 A380 飞机在莫斯科多莫杰多沃机场发生地面事 故。🔻目前的消息是59岁的地面车司机在驾驶中突然中风了，失去了对车辆的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70qltlgv/">
    
    
    
    
    
      
    
    🔻注册号为 A6-EDM 的阿联酋航空公司 A380 飞机在莫斯科多莫杰多沃机场发生地面事 故。<!-- raw HTML omitted -->🔻目前的消息是59岁的地面车司机在驾驶中突然中风了，失去了对车辆的控制，目前正在医院。<!-- raw HTML omitted -->🔻啊这……<!-- raw HTML omitted -->🔻由于在俄罗斯维修此类飞机的能力下降，受损的 A380 给运营商带来了挑战。<!-- raw HTML omitted -->🔻源：Flightradar24、Ньюсач/Двач<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70TFrfQV">在折叠和平板的选择中纠结的原因，主要是出门的便携性：如果折叠能满足需求，就可以少带个大包，不然就算是背ipad mini出门也得带大包，还不如直接上11-12寸的平...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70tfrfqv/">
    
    
    
    
    
      
    
    在折叠和平板的选择中纠结的原因，主要是出门的便携性：如果折叠能满足需求，就可以少带个大包，不然就算是背ipad mini出门也得带大包，还不如直接上11-12寸的平板……<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻问一个问题，vivo 这种安卓折叠屏，在实际使用中能替代 ipad 用来读论文和开多窗口发微博么？<!-- raw HTML omitted -->🔻想买一个试试看，但是对折痕有点膈应。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70YEeHsu">我有很多笔记本了，我现在是需要在手机和笔记本之间再补充一个更轻一点的。//@sj2wk:为什么你没有考虑微软的surface呢？？ - 转发 @包容万物恒河水:&amp;ensp;🔻问...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70yeehsu/">
    
    
    
    
    
      
    
    我有很多笔记本了，我现在是需要在手机和笔记本之间再补充一个更轻一点的。//<!-- raw HTML omitted -->@sj2wk<!-- raw HTML omitted -->:为什么你没有考虑微软的surface呢？？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻问一个问题，vivo 这种安卓折叠屏，在实际使用中能替代 ipad 用来读论文和开多窗口发微博么？<!-- raw HTML omitted -->🔻想买一个试试看，但是对折痕有点膈应。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O710GmVGX">🔻以色列没招了。🔻源：半岛。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o710gmvgx/">
    
    
    
    
    
      
    
    🔻以色列没招了。<!-- raw HTML omitted -->🔻源：半岛。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71fQDg30">🔻看了几集，这位老师的社会科学概论确实讲的不错。🔻概论类，有提炼、有想法、有研究，而且很会讲课，不是简单的念PPT，上课内容有灵魂。🔻看了下C刊论文...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71fqdg30/">
    
    
    
    
    
      
    
    🔻看了几集，这位老师的社会科学概论确实讲的不错。<!-- raw HTML omitted -->🔻概论类，有提炼、有想法、有研究，而且很会讲课，不是简单的念PPT，上课内容有灵魂。<!-- raw HTML omitted -->🔻看了下C刊论文，这位老师主要是做信息资源管理方向研究的。其实信息学、图书馆学就是“情 报 学”，我们熟悉的“搜索引擎”、“思维导图”、“开源情报分析”等等概念，与这些基础学科技能分不开。<!-- raw HTML omitted -->🔻高校里社科类有很多这样默默做学问的老师，他们平时也不玩自媒体。<!-- raw HTML omitted -->🔻然而大家对高校社科类的坏印象往往都来自一些好出名但是不好做学问的高校人。<!-- raw HTML omitted -->🔻地址是：<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;/sp &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71iREVrX">看，根本没有人关心波兰。晚安。//@乖哈33:所以是博美还是萨摩耶？ - 转发 @包容万物恒河水:&amp;ensp;🔻在访问部队时，卢卡申科与一名指挥官交谈，向他询问了对抗...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71irevrx/">
    
    
    
    
    
      
    
    看，根本没有人关心波兰。晚安。//<!-- raw HTML omitted -->@乖哈33<!-- raw HTML omitted -->:所以是博美还是萨摩耶？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻在访问部队时，卢卡申科与一名指挥官交谈，向他询问了对抗波罗的海国家和夺取波兰部分领土以便将白俄罗斯与加里宁格勒连接起来的战略。<!-- raw HTML omitted -->🔻但是很多人只关注了卢卡申科在 rua 一条狗。<!-- raw HTML omitted -->🔻源：白通社 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;sp &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71lcuGrp">🔻6🔻源：半岛 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71lcugrp/">
    
    
    
    
    
      
    
    🔻6<!-- raw HTML omitted -->🔻源：半岛 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71vljcaf">🔻啊？？？🔻[费解]🔻是的，我知道这是黑袍纠察队的衍生剧……🔻但是，怎么成这个样子了…… 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71vljcaf/">
    
    
    
    
    
      
    
    🔻啊？？？<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->🔻是的，我知道这是黑袍纠察队的衍生剧……<!-- raw HTML omitted -->🔻但是，怎么成这个样子了…… <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71yw9lt6">？ 评论配图 - 转发 @包容万物恒河水:&amp;ensp;🔻啊？？？🔻[费解]🔻是的，我知道这是黑袍纠察队的衍生剧……🔻但是，怎么成这个样子了…… 包容万物恒河水...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71yw9lt6/">
    
    
    
    
    
      
    
    ？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->评论配图<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻啊？？？<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->&lt;img alt=&quot;[费解]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_feijie-c1df37ef03.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_feijie-c1df37ef03.png&quot;</a> style=&ldquo;width:1em; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O6UkxC8qx">微博很荒诞的流量机制 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o6ukxc8qx/">
    
    
    
    
    
      
    
    微博很荒诞的流量机制 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O6XNBpe1t">心情复杂 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o6xnbpe1t/">
    
    
    
    
    
      
    
    心情复杂 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O708l5vW6">烟鬼们真傻逼啊[哆啦A梦害怕] [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o708l5vw6/">
    
    
    
    
    
      
    
    烟鬼们真傻逼啊<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O7034ft4n">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.nogi46ann&amp;nogizaka46 X [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o7034ft4n/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogi46ann&amp;nogizaka46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1ho5z4cncouj31530u">https://tvax1.sinaimg.cn/large/006z6nxLgy1ho5z4cncouj31530u</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O70e8wa0U">啊？//@想林的衰衰TvT:[哆啦A梦吃惊]//@西野慧:[傻眼]//@CXBLD:[哆啦A梦害怕] - 转发 @竹无心jk:&amp;ensp;桥本奈奈未看👀图片有惊喜娜娜敏[哈哈][哈哈][哈哈]图来...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o70e8wa0u/">
    
    
    
    
    
      
    
    啊？//<!-- raw HTML omitted -->@想林的衰衰TvT<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@西野慧<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@CXBLD&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O718jag2I">好喜欢打游戏啊🥹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o718jag2i/">
    
    
    
    
    
      
    
    好喜欢打游戏啊🥹  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719JoDfl">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.03.27 12:48「崭新的」你好今天不用打开窗帘也能知道是晴天，很开心不过，不管是雨天还是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719jodfl/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%25">https://m.weibo.cn/search?containerid=231522type%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719Lm6Mm">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.03.27 15:44「音乐」今天的晚餐你要吃什么？☺︎我要吃什么好呢。你喜欢的蔬菜是什么。今...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719lm6mm/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D1">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719OyP3o">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.03.27 19:43「欸嘿嘿」最近，只是稍微努力一点就会感到疲倦，觉得困。。得逐渐重新提升体...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719oyp3o/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26">https://m.weibo.cn/search?containerid=231522type%3D1%26</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719VnNb7">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# .#久保的排练服##YABAIYO##YABAIYO##出川哲朗# 桑#今晚是这个年度最后的##开幕前最后的##乃木坂46ANN...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719vnnb7/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O71a2ayOD">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 稍后22:00～（JST）富士电视网『週刊ナイナイミュージック』请一定要观看🕺🏻非常开心能久违地跟...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o71a2ayod/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O71feyp0o">感觉古风歌我又爱听了🥹🫰🏻</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o71feyp0o/">
    
    
    
    
    
      
    
    感觉古风歌我又爱听了🥹🫰🏻  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O71uPmayW">唉，真的喜欢绪儿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o71upmayw/">
    
    
    
    
    
      
    
    唉，真的喜欢绪儿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6UKSmJNT">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 最近，我经常跟大概是去了大学毕业典礼的人擦身而过。恭喜毕业。如果我也是大学生的话，也是要毕业的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6uksmjnt/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6UKtF4pc">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.03.26 22:38「呜呼呼」说起来我没在任何地方发封面照的花絮照呢。比平常更有情调的卷发方...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6uktf4pc/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6ZLw5sV2">真好看 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6zlw5sv2/">
    
    
    
    
    
      
    
    真好看 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6Zni6hVp">分享图片 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6zni6hvp/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O70bH0tOB">宮城26號還在下雪 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o70bh0tob/">
    
    
    
    
    
      
    
    宮城26號還在下雪 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6WEgDAf8">第24届阿含桐山杯中日对抗赛，最终杨鼎新中盘战胜一力辽获得优胜。以下是双方赛后感想：杨鼎新：【回顾今天这盘棋，然后什么时候意识到赢棋了】一开始白棋在上面...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6wegdaf8/">
    
    
    
    
    
      
    
    第24届阿含桐山杯中日对抗赛，最终杨鼎新中盘战胜一力辽获得优胜。以下是双方赛后感想：<!-- raw HTML omitted --><!-- raw HTML omitted -->杨鼎新：<!-- raw HTML omitted -->【回顾今天这盘棋，然后什么时候意识到赢棋了】一开始白棋在上面跳了挡下去然后靠过来，那个时候黑棋还很厚，白棋挺薄，那个时候感觉还可以。左边黑棋大飞的时候感觉左边不太好做活，这个时候感觉白棋还可以。<!-- raw HTML omitted --><!-- raw HTML omitted -->【优胜之后感受如何】首先非常感谢阿含宗这么多年的支持和努力，得以继续举办。然后中日对抗的传统也保留下来，身为棋手非常感激。阿含宗的对局环境非常好，我在中国和世界大赛中没有过这么好的环境对局，对此非常感谢。<!-- raw HTML omitted --><!-- raw HTML omitted -->一力辽：<!-- raw HTML omitted -->【回顾一下今天这盘棋】布局阶段每一手棋都比较复杂，实战被黑棋连片之后感觉不太好下，或许之前有更好的下法。左边的局面眼见的非常难下，只能选择治孤。实战治孤的难度也非常大。<!-- raw HTML omitted --><!-- raw HTML omitted -->【这是你第2次参加中日对抗，对下一届比赛，以及对今后的世界大赛有什么想法】这一次和5年前的结果都很遗憾，棋局的内容也很糟糕。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6WghBZWQ">杨鼎新：好像盘腿坐也不是不行#围棋#围棋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6wghbzwq/">
    
    
    
    
    
      
    
    杨鼎新：好像盘腿坐也不是不行<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6WKErgRa">不相信只有我第一感会觉得，中间C位的神秘嘉宾是申真谞#围棋#围棋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6wkergra/">
    
    
    
    
    
      
    
    不相信只有我第一感会觉得，中间C位的神秘嘉宾是申真谞<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6XTc4k1C">※ 同一人物#围棋#围棋 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6xtc4k1c/">
    
    
    
    
    
      
    
    ※ 同一人物<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/00">https://tvax1.sinaimg.cn/large/00</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O7007kQUE">阿含桐山杯中日对抗，看完了这两天的报道，一力辽除了人在日本，总感觉像是在客场作战，反倒是杨鼎新游刃有余。无论是报道团队，还是赛后复盘，都是我们中方更加...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o7007kque/">
    
    
    
    
    
      
    
    阿含桐山杯中日对抗，看完了这两天的报道，一力辽除了人在日本，总感觉像是在客场作战，反倒是杨鼎新游刃有余。<!-- raw HTML omitted --><!-- raw HTML omitted -->无论是报道团队，还是赛后复盘，都是我们中方更加积极。日本方面除了阿含宗鼎力支持赛事之外，我觉得日本媒体都没有我们用心。<!-- raw HTML omitted --><!-- raw HTML omitted -->所以日本围棋成绩不好只是一个很残酷的结果，在这个结果背后其实有很多很多拉胯的地方。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O701NaDjJ">发布了头条文章：《杨鼎新全场压制一力辽，屠龙完胜》 #围棋# 围棋 杨鼎新全场压制一力辽，屠龙完胜 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o701nadjj/">
    
    
    
    
    
      
    
    发布了头条文章：《杨鼎新全场压制一力辽，屠龙完胜》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O6ZczxvPg">久保史绪里 - 转发 @山下美月教会:&amp;ensp;山下美月 240327「週刊ナイナイミュージック」チャンスは平等 山下美月教会的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o6zczxvpg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%9C%88&amp;amp;containerid=10080893">https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%9C%88&amp;amp;containerid=10080893</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O6ZeYkqF0">久保史绪里via.週刊ナイナイミュージック [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o6zeykqf0/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.週刊ナイナイミュージック <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLg">https://tvax3.sinaimg.cn/large/006z6nxLg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O6ZZ0m6DL">久保史绪里via.nogi46ann&amp;nogizaka46 X [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o6zz0m6dl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogi46ann&amp;nogizaka46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006">https://tvax2.sinaimg.cn/large/006</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70FczSaE">久保史绪里#久保史绪里手机博# 2024.03.27 12:48「崭新的」你好今天不用打开窗帘也能知道是晴天，很开心不过，不管是雨天还是晴天，最近我起床都有些费力。要找...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70fczsae/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70FlsUX1">久保史绪里#久保史绪里手机博# 2024.03.27 15:44「音乐」今天的晚餐你要吃什么？☺︎我要吃什么好呢。你喜欢的蔬菜是什么。今天早上呢，突然思念起夏天震惊了呢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70flsux1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isn">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70FsqGDy">久保史绪里#久保史绪里手机博# 2024.03.27 19:43「欸嘿嘿」最近，只是稍微努力一点就会感到疲倦，觉得困。。得逐渐重新提升体力才行。呼～，一边这么说，我也打...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70fsqgdy/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;a">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;a</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70LMxIqv">久保史绪里#shiorigram# .#久保的排练服##YABAIYO##YABAIYO##出川哲朗# 桑#今晚是这个年度最后的##开幕前最后的##乃木坂46ANN##要听哦#※YABAIYO YABAIYO（糟了...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70lmxiqv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->.<!-- raw HTML omitted -->&lt;a  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70MajVYs">久保史绪里#shiorigram# 稍后22:00～（JST）富士电视网『週刊ナイナイミュージック』请一定要观看🕺🏻非常开心能久违地跟ナイナイ桑和森田桑见面…🌱half ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70majvys/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U1qp6Tl">柯洁#农心杯##赛事报道# 视频来源:央5 体育世界网页链接 柯洁九段新闻搬运号的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u1qp6tl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#农心杯#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=2">https://m.weibo.cn/search?containerid=2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U28j61X">柯洁#西南棋王赛##赛事报道# 视频来源:央5 体育新闻网页链接 柯洁九段新闻搬运号的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u28j61x/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#西南棋王赛#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?container">https://m.weibo.cn/search?container</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U2DrieA">柯洁#西南棋王赛# #赛事报道# 视频来源:央5 体坛快讯网页链接 柯洁九段新闻搬运号的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u2driea/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#西南棋王赛#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containe">https://m.weibo.cn/search?containe</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U3c2VEO">柯洁#西南棋王赛##赛事报道# 视频来源:央5 体育新闻网页链接 柯洁九段新闻搬运号的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u3c2veo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#西南棋王赛#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?container">https://m.weibo.cn/search?container</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U3L3SDC">柯洁#雅居乐清水湾杯中国围棋甲级联赛##赛事报道# 视频来源:央5 体坛快讯网页链接 柯洁九段新闻搬运号的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u3l3sdc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U4ebht0">柯洁#雅居乐清水湾杯中国围棋甲级联赛##赛事报道# 视频来源:央5 体育新闻网页链接 柯洁九段新闻搬运号的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u4ebht0/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

